30 closest matches · ranked by relevance
Chronic Total Occlusion · Ischemic Heart Disease · Chronic Total Occlusion of Coronary Artery
Primary: Number of Participants With Procedure Success — 121 Participants
Total Atherosclerotic Occlusion of Femoral Artery
Primary: Primary Safety Endpoint — 2 Percent of participants
Coronary Artery Disease · Coronary Artery Chronic Total Occlusion
Primary: Procedure Success — 119 Participants
Chronic Total Occlusion
Primary: Composite Rate of Major Adverse Events — 3.3 percentage of participants
Coronary Artery Disease (CAD) · Chronic Total Occlusion (CTO)
Primary: Number of Participants With Stent-related: Major Adverse Cardiac Events (MACE) (Per ITT Set) — 39 Participants
Peripheral Arterial Disease
Primary: Major Adverse Events — 4 participants
Critical Limb Ischemia · Peripheral Arterial Disease
Primary: Primary Effectiveness Endpoint: Late Lumen Loss (LLL) at 9 Months — 0.892; 1.312 mm
Cardiovascular Diseases · Heart Diseases · Myocardial Infarction
Primary: Number of Patients That Had a First Occurrence of the Primary End Point (Composite of Death From Any Cause, Nonfatal MI, or Class IV HF) — 230; 219 participants
Coronary Artery Chronic Total Occlusion
Primary: Technical Success — 77 percentage of CTOs
Peripheral Arterial Disease
Primary: Crossing the Target Lesion — 60 Participants
Peripheral Artery Disease
Primary: Safety Endpoint: Number of Participants With Freedom From Major Adverse Events — 110 Participants
Peripheral Artery Occlusion · Peripheral Arterial Disease
Primary: Clinical Success of AngioSafe Peripheral CTO Crossing System — 65 Participants
Critical Limb Ischemia
Primary: To Determine Platelet Inhibition Before and After Switching for Two Weeks From Clopidogrel to Ticagrelor in Patients With CLI. — 173; 140; 71; 63 P2Y12 reaction units…
PAD · Vascular Calcification
Primary: Device Success — 42; 39 Drug Coated Balloons
Coronary Artery Disease · Atherosclerosis
Primary: Minimum Stent Area After Percutaneous Coronary Intervention — 6.7; 6.9 mm^2
Peripheral Arterial Disease
Primary: Device Technical Success — 29 lesions
Peripheral Arterial Disease
Primary: Technical Success — 144 lesion
Peripheral Vascular Disease
Primary: The Number of Participants With Major Adverse Events (MAE) — 0 participants
Peripheral Artery Disease
Primary: Visualization of Vessel Morphology: Layered Structure — 1.61; 1.49 score on a scale
Coarctation of the Aorta
Primary: Change in Difference Between Arm and Leg Systolic Blood Pressure From Baseline to 12 Months — 30 mmHg
Critical Limb Ischemia
Primary: Number of Participants With Freedom From Below-the-Knee (BTK) Major Adverse Limb Event and Peri-Operative Death (POD) at 30 Days Post Index Procedure. — 284; 154…
Coronary Artery Disease
Primary: MLD SB Diameter — 08.; 1.0; 2.3; 2.2 mm
Peripheral Artery Disease
Primary: Efficacy - Number of Subjects That Met Primary Patency Criteria at 12 Months — 120 Participants
Chronic Total Occlusion of Artery of the Extremities
Primary: Number of Lesions With Successful CTO Crossing Assessed by Angiography — 77 lesions
Peripheral Vascular Disease
Primary: Major Adverse Event (MAE) Rate — 11.0 percentage of participants
Peripheral Vascular Diseases
Primary: Event-free Survival Rate — 90.4; 83.9 Percentage of participants — p=<0.01
Peripheral Arterial Disease · Claudication · Critical Limb Ischemia
Primary: Primary Patency Rate (in Patients Treated for Claudication RCC 1-3) — 81.6 percentage of lesions by Kaplan Meier
Peripheral Arterial Disease
Primary: Efficacy - Number of Participants With Freedom From MALE at 6 Months and POD at 30 Days — 200 Participants
Peripheral Artery Disease
Primary: Plaque Volume — 10.5; 10.5; 10.8 cm^3 — p=0.32
Coronary Artery Disease
Primary: Primary Safety Endpoint: 30-Day Freedom From Major Adverse Cardiac Events (MACE) — 89.6 Percent probability of Freedom from MACE